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xxBrigham and Whe current paper details the recommendations arising from an NIH-NHLBI/NCI-sponsored symposium held
in November 2012, aiming to identify key components of a radiation accountability framework fostering
patient-centered imaging and shared decision-making in cardiac imaging. Symposium participants, working in
3 tracks, identiﬁed key components of a framework to target critical radiation safety issues for the patient, the
laboratory, and the larger population of patients with known or suspected cardiovascular disease. The use of ionizing
radiation during an imaging procedure should be disclosed to all patients by the ordering provider at the time of
ordering, and reinforced by the performing provider team. An imaging protocol with effective dose 3mSv is
considered very low risk, not warranting extensive discussion or written informed consent. However, a protocol
effective dose >20mSv was proposed as a level requiring particular attention in terms of shared decision-making
and either formal discussion or written informed consent. Laboratory reporting of radiation dosimetry is a critical
component of creating a quality laboratory fostering a patient-centered environment with transparent procedural
methodology. Efforts should be directed to avoiding testing involving radiation, in patients with inappropriate
indications. Standardized reporting and diagnostic reference levels for computed tomography and nuclear cardiology
are important for the goal of public reporting of laboratory radiation dose levels in conjunction with diagnostic
performance. The development of cardiac imaging technologies revolutionized cardiology practice by allowing
routine, noninvasive assessment of myocardial perfusion and anatomy. It is now incumbent upon the imaging
community to create an accountability framework to safely drive appropriate imaging utilization. (J Am Coll
Cardiol 2014;63:1480–9) ª 2014 by the American College of Cardiology FoundationSee page 1490Cardiac imaging procedures have come under increasing
scrutiny as a result of high utilization volume, concerns over
inappropriate use, a lack of adherence to quality control, and
the potential of cancer risks attributable to ionizing radiation
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1481guide patient referrals for testing (1–4). These issues have
prompted concerns as to the extent to which current practice
patterns are aligned with patient-centered imaging quality,
particularly those related to radiation safety principles of
justiﬁcation and optimization.
The Institute of Medicine report on healthcare quality of
more than a decade ago deﬁned key dimensions of quality
healthcare delivery as those that provide services on the basis of
the highest level of scientiﬁc evidence and that demonstrate a
clear beneﬁt in terms of improved patient-centered outcomes
(5). The Institute of Medicine’s 6 aims for quality improve-
ment are safety, effectiveness, patient-centeredness, timeli-
ness, efﬁciency, and equity (5); all of these are critical elements
for driving patient-centered imaging. Importantly, refraining
from providing services that are unlikely to beneﬁt is a key
element of quality health care. The latter brings to the fore-
front the issue of patient safety and avoiding unnecessary
potential harm to patients as a result of procedural overuse (5).
The goal of radiological protection is the safeguarding of
people from potentially harmful effects of ionizing radiation,
while ensuring the beneﬁts related to its use. Accordingly,
both dedicated radiological protection organizations (6,7)
and medical societies (8–16) have put forth documents to
educate members of the cardiovascular imaging community
aimed at improving physician decision making with regard
to radiation safety. The current report details the recom-
mendations arising from an symposium sponsored by the
National Heart, Lung, and Blood Institute and the National
Cancer Institute titled Patient-Centered Imaging: Shared
Decision Making for Cardiac Imaging Procedures With
Exposure to Ionizing Radiation, held at Emory University,
November 15 to 17, 2012. The overarching goal of this
symposium was to build on prior statements and identify
key components of an accountability framework to guide
the development of quality imaging and to target critical
radiation safety issues for patients and laboratories, and for
management of the larger population of patients at risk for
cardiovascular disease. Three tracks were included in this
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2013, accepted October 28, 2013.for: 1) patients; 2) laboratories;
and 3) the overall population. The
goals and discussion points for
each track are detailed in Table 1.
Focus on Patient–Physician
Shared Decision Making
This section aimed to develop a
framework for patient involve-
ment in decisions about radiation
exposure and to provide patients and the broader clinical
community with language that clearly describes and properly
contextualizes the risk of exposure to ionizing radiation. The
approach outlined in this document is consistent with
ethical responsibilities of respect to patients as decision
makers and with the recognition that improved patient de-
cision making is a means to advance quality and safety in
health care (17).
Physician locus of responsibility for shared decision
making. A recent study revealed that most patients un-
dergoing cardiovascular computed tomographic (CT) im-
aging or single-photon emission CT (SPECT) imaging
were either unaware that these procedures expose them to
ionizing radiation or were insufﬁciently informed of the
potential radiation exposure risk (18). An ensuing question
is who should take primary responsibility for fully informing
patients. The consensus from this symposium was that
both referring and laboratory physicians should share re-
sponsibility for both justiﬁcation of the test exposure to
ionizing radiation (6) and patient education.
Any approach to facilitate patient decision making must
acknowledge this shared responsibility. Ideally, both the
referring provider and the imager should be sufﬁciently
knowledgeable about the beneﬁts and risks of the requested
imaging study, and discuss this in sufﬁcient detail with the
patient, to optimally guide decision making. In practice, the
referring provider typically has the best understanding of the
beneﬁts of an imaging procedure for a patient’s speciﬁc
clinical scenario. Referral must be based on appropriate use
(19,20), and the referring provider’s communication with
patients should include some disclosure of radiation and
other risks associated with the test. If a patient is confronted
on arrival to the imaging laboratory with risk information
that was previously unknown, the patient would likely have
little context for using that information in a meaningful
manner, so the primary discussion regarding the risks and
beneﬁts of imaging should be held at the time of ordering.
Yet the imaging provider has a better understanding of the
amount of radiation to be used as well as types and prob-
abilities of health risks related to radiation exposure. As
such, imaging laboratories should assume the responsibility
for providing educational materials to guide referring
physicians’ discussions with patients. In the imaging labo-
ratory, the procedural information sheet (containing prep-
aration requirements and procedural methods) that is
Table 1 Conference Discussion Points
Focus on the patient
Transparent explanation of radiation risk that results in informed patient
decision making
Informed consent: patient and physician decision aids
New communication models to optimize patient preferences for test selection
and timely reporting
Focus on the laboratory
Demonstrated safety proﬁle for laboratory accreditation
Demonstrated physician/staff member knowledge for certiﬁcation
Performance metrics for radiation safety tracking
Public reporting of beneﬁt and risk
Comparative effectiveness: integration of safety into multimodality decision
making
Focus on the population
AUC as a means to drive safety: is it sufﬁcient?
Effective assimilation of low-dose alternatives (e.g., rubidium-82 PET)/dose
reduction techniques
Optimal continuous quality initiatives: hurdles beyond the research environment
Future information technology and research developments: tracking and
standardized reporting
AUC ¼ appropriate use criteria; PET ¼ positron emission tomography.
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1482generally provided to patients should also acknowledge ra-
diation exposure, justiﬁcation for the procedure, and the
laboratory’s standard practice of dose optimization. Con-
cerned professional societies and/or individual imaging
centers should develop information booklets that can be
provided, both at the point of referral and in the imaging
laboratory, to patients who wish to learn, in greater detail,
about the proposed cardiac imaging procedure. Throughout
the referral and imaging process, patients should be
encouraged to ask questions about appropriate use, proce-
dural justiﬁcation, and dose optimization practices for a
given laboratory (10).
Electronic decision support tools may play a role in
assisting referring practitioners and fostering improved refer-
ral patterns targeted toward high rates and improved identi-
ﬁcation of appropriate indications for testing at the point of
ordering. The laboratory physician has the responsibility to
conﬁrm the appropriateness of a referral for a given patient
and to provide added guidance to the patient regarding pro-
jected radiation exposure risk. At times, discrepancies in un-
derstandings of the patient’s clinical status and the particular
implications of the proposed test should prompt direct
communication between these providers. The current man-
date for tracking of patient satisfaction within healthcare
services should also help promote improved communication
between physicians and patients (21).
Communicating radiation-related health risks. Com-
municating with patients in a way that facilitates effective
shared decision making is a complex process that must ac-
count for patients’ levels of engagement, be sensitive to
prevalent limitations in health literacy, and focus on elements
that are most relevant to the medical decision at hand.
Several speciﬁc elements are essential to communication
regarding the description of a procedure exposing a patient toionizing radiation. First, physicians and other healthcare
providers should be aware that patients attribute both posi-
tive (i.e., a medical beneﬁt of diagnosis or risk assessment)
and negative (i.e., fear of the danger of cancer) feelings to-
ward radiation exposure, and that concerns regarding radia-
tion risks are prevalent (22). Second, patients should be made
aware that a given procedure requires exposure to ionizing
radiation and that radiation exposure is present in the natural
environment and a part of our everyday lives. Third, patients
should be informed qualitatively of the expected radiation
dose, with comparison made with a familiar form of radia-
tion, such as a chest x-ray, a transcontinental airplane ﬂight,
or annual background radiation, and of efforts to reduce
exposure. Fourth, the potential risk related to radiation
should be contextualized within the appropriateness of the
procedure and the established beneﬁt of accurate information
to guide clinical decision making. Finally, available alterna-
tives that do not require exposure to ionizing radiation (e.g.,
alternative imaging or no testing) and their relative risks and
beneﬁts should be discussed, as applicable.
Communicating remote and uncertain risks to patients is
challenging for multiple reasons, including limited health
numeracy skills and comprehension difﬁculties in risk-based
decision making, the latter of which is common in medicine
but foreign to most patients (23). The framework for dis-
cussions on projected radiation risk should include com-
parison to the background population risk of cancer.
Research has also shown that there is greater patient un-
derstanding of risk when comparisons are made with com-
mon daily scenarios, such as the risk for dying as a result of
activities of everyday life (24), activities that increase the
chance of death (25), and the concept of “lost life expec-
tancy” related to activities of everyday life (26). Thus, pati-
ents should have a frame of reference for a common scenario
of risk, their average cancer risk, and how their risk would
change after exposure to ionizing radiation.
In addition to these content items, there are established
communication tools, including the use of “plain language”
(27) and the “teach-back” method (28), that improve patient
comprehension (29). The use of graphical representations
of risk or other alternative ways of presenting risk infor-
mation also promotes engagement and improves compre-
hension of complex concepts of risk (30). Resources are
available from the National Cancer Institute, which recently
published a series on patient-centered communication (31).
Optimal ways of communicating radiation risk to cardio-
vascular patients warrant further study.
The following list was synthesized by symposium partici-
pants to provide guidance for communicating risks and ben-
eﬁts after radiation exposure from cardiovascular imaging (32):
1. There is low “numeracy” literacy among the U.S.
population that impairs understanding of health risks;
thus, avoid statistical terms and constructs (33).
2. Use analogies for the projected risk of radiation
exposure, using simple comparisons (34).
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comparisons.
4. Make clear the difference between the baseline risk for
cancer and the projected risk for cancer after radiation
exposure.
5. Provide patient decision aids to enhance comprehen-
sion, including the use of pictographs and visual aids
comparing incremental risk and beneﬁt.
Deﬁning levels of informed consent. Standard practice
across many institutions is not to obtain formal written
informed consent for or discuss the risks of radiation expo-
sure with patients for many imaging procedures (35–39).
Among the symposium participants, there was vigorous dis-
cussion about the prudence of written informed consent for
patients, ultimately with divergent perspectives. Consensus
was achieved with regard to the need for more robust dis-
closure and involvement of patients in these decisions, that
radiation-related risks are in the public consciousness, and
that formal disclosure of associated risks promotes trans-
parency in physician decision making. Especially when
alternative procedures exist, there is a case for also providing
patients with that information. Given these prior statements,
discussion of radiation exposure may serve to inform de-
cisions, alleviate fears and misconceptions about radiation
risk, and promote trust between patients and physicians.
A secondary line of discussions focused on whether
a given threshold of radiation exposure should prompt
patient–physician discussions and/or written informed con-
sent. Symposium participants agreed that the answers to
radiation-related questions depend signiﬁcantly on the level
of exposure. Rational tiers of radiation burden that were
discussed relevant to the patient–physician interaction were
those that were based on levels of radiation exposure that are
standard levels used in other contexts. These levels included
3 mSv (the average annual background level of radiation in
the United States), 20 mSv (the recommended average
annual occupational dose limit for adults) (40), and 50 mSv
(the single-year occupational dose limit for adults) (41).
Given the uncertainty in estimates for radiation dose and
radiation-attributable risk, additional granularity of effective
doses was not recommended by the symposium participants.
A procedure with effective dose that is less than the average
annual background level of radiation in the United States (i.e.,
3 mSv) is considered to have very low radiation risk. Thus,
general consensus opinionwas reached that for imaging studies
with an effective dose of3 mSv, “radiation risk” need not be
extensively discussed. Within the imaging laboratory, written
information should be available that discloses the use of radi-
ation and the very low projected risk that is associated with this
low level of exposure; this approach is analogous to the com-
mon practice of prescribing medications that are of minimal
risk, whereby an abbreviated discussion with a provision of
written materials by the pharmacist is accepted practice.
For procedures for which the effective dose of the
protocol expected to be used exceeds a threshold of 20 mSv,consensus opinion supported a recommendation whereby
any patient undergoing such a protocol would have either a
formal discussion with the physician or written informed
consent with regard to radiation exposure and projected
cancer risk. This threshold was recommended speciﬁcally
for an individual procedure, for example, a SPECT myo-
cardial perfusion imaging stress testing procedure for the
assessment of ischemia and/or scarring, and not for appro-
priate sequential testing performed as part of the manage-
ment strategy for a patient, such as stress testing with
myocardial perfusion imaging followed by assessment of
myocardial viability or angiography. For individual patients,
sequential tests, if carefully selected, may provide vital in-
formation not obtainable by other means. Protocols in excess
of 20 mSv (Table 2) include dual-isotope nuclear stress
testing protocols on conventional SPECT cameras and
many 120-kV, low-pitch, helical, retrospectively gated cor-
onary CT angiographic protocols (6,8,42). By identifying a
threshold at which a more formal discussion or written
informed consent would occur, the majority of sympo-
sium participants believed that this would ensure a level
of consistency in disclosure across patient cohorts. This
recommendation fosters shared decision making for those
procedures with the highest radiation exposures of all med-
ical imaging procedures and has the added beneﬁt of po-
tentially serving as a deterrent to using such protocols when
not clinically warranted. A similar strategy is applied to
the use of contrast media for imaging, for which informed
consent for contrast-related risks (i.e., allergy, anaphylaxis,
or nephropathy) is commonly obtained in current clinical
practice, although the risk is low and disclosure is not
required by law. Speciﬁc dose-sensitive template language
describing potential radiation risk was suggested by the
symposium participants and could be included in a written
informed consent or used during an informational discussion
between the patient and physician (Table 3). The patient–
physician discussion should be documented in the patient’s
procedural ﬁnal report.
Some participants expressed practical concerns that clinical
workﬂow would be impeded if written informed consent
were routinely implemented for a large sector of patients.
Disruptions in workﬂow could then promote a rushed or
ineffective communication to patients without sensitivity to
health literacy issues and may increase patients’ fears during
the informed consent process. It was suggested that para-
digms other than traditional written informed consent war-
rant exploration and may more effectively promote patient
comprehension of radiation risk and test decision making.
Additionally, the inclusion of patient-speciﬁc dose and
risk estimates during the discussion was thought to be
generally impractical because of their predictive uncertainty
and the logistical challenges of providing multiple strategies
for discussions across varying patient ages, sex, life expec-
tancies (43), and body sizes.
Conclusions. The use of ionizing radiation during imaging
procedures should be disclosed to all patients by the ordering




MDCT Coronary CT angiography:
helical, no tube current modulation
8–30
MDCT Coronary CT angiography:
helical, tube current modulation
6–20
MDCT Coronary CT angiography:
prospectively triggered axial
0.5–7
MDCT Coronary CT angiography:
high-pitch helical
<0.5–3




MDCT Calcium score 1–5
MDCT Attenuation correction <0.5–2
EBCT Calcium score 1
SPECT 10 mCi 99mTc sestamibi rest/
30 mCi 99mTc sestamibi stress
11
SPECT 15 mCi 99mTc sestamibi rest/
45 mCi 99mTc sestamibi stress
17
SPECT 30 mCi 99mTc sestamibi stress/
30 mCi 99mTc sestamibi rest
18
SPECT 10 mCi 99mTc sestamibi stress only 2.7
SPECT 30 mCi 99mTc sestamibi stress only 8
SPECT 10 mCi 99mTc tetrofosmin rest/
30 mCi 99mTc tetrofosmin stress
9
SPECT 15 mCi 99mTc tetrofosmin rest/
45 mCi 99mTc tetrofosmin stress
14
SPECT 30 mCi 99mTc tetrofosmin stress/
30 mCi 99mTc tetrofosmin rest
14
SPECT 10 mCi 99mTc tetrofosmin stress only 2.3
SPECT 30 mCi 99mTc tetrofosmin stress only 7
SPECT 3.5 mCi 201Tl 15
SPECT Dual isotope: 3.5 mCi 201Tl rest/
30 mCi sestamibi stress
23
SPECT Dual isotope: 3.5 mCi 201Tl rest/
30 mCi tetrofosmin stress
22
PET 50 mCi 82Rb rest/50 mCi 82Rb stress 4
PET 15 mCi 13N ammonia rest/
15 mCi 13N ammonia stress
2
PET 10 mCi 18F FDG 7
Planar 30 mCi 99mTc-labeled erythrocytes 8
Fluoroscopy Diagnostic invasive coronary angiography 2–20
Fluoroscopy Percutaneous coronary intervention 5–57
Fluoroscopy TAVR, transapical approach 12–23
Fluoroscopy TAVR, transfemoral approach 33–100
Fluoroscopy Diagnostic electrophysiologic study 0.1–3.2
Fluoroscopy Radiofrequency ablation of arrhythmia 1–25
Fluoroscopy Permanent pacemaker implantation 0.2–8
CT ¼ computed tomographic; EBCT ¼ electron-beam computed tomography; FDG ¼ ﬂuorodeoxy-
glucose; MDCT ¼ multidetector-row computed tomography; PET ¼ positron emission tomography;
SPECT ¼ single-photon emission computed tomography; TAVR ¼ transcatheter aortic valve
replacement.
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1484physicians at the time of ordering and reinforced by the
performing provider team. Simple and clear language should
be used to communicate potential radiation risk. A scan with
a protocol effective dose of 3 mSv is considered very low
risk and was generally agreed not to require a detailed
discussion or written consent. However, when the protocol
effective dose exceeds 20 mSv, speciﬁc information
regarding radiation risk should be included in a patient–physician discussion or in the form of written informed
consent to ensure more substantial patient involvement in
the decision. Studies evaluating the actual impact of
different patient-involvement strategies on patient compre-
hension, satisfaction, and trust, as well as important logis-
tical aspects of practice, will help reﬁne patient-centered
approaches to the inclusion of discussions on radiation be-
tween physicians and patients.
Focus on Laboratory Reporting and Tracking
The goals of this section were to address approaches for
improving laboratory quality with regard to radiation expo-
sure; its ﬁndings focus on the need for development of
diagnostic reference levels (DRLs) and strategies for public
reporting for imaging laboratories.
Demonstrated physician and staff member knowledge
base in radiation safety. Limitations in the knowledge
bases of physicians and other healthcare providers about
radiological protection have been reported (44,45). In a
recent American Society of Nuclear Cardiology (ASNC)
survey, the proportion of physicians with adequate radiation
dosimetry knowledge was found to be suboptimal; with only
1 in 10 physicians understanding comparative test radiation
exposure levels (1). Physicians, technologists, and nurses
working in an imaging laboratory need to have a working
knowledge of radiation doses and an awareness of radiation
dose reduction strategies. Knowledge assessment and stan-
dardized curricula of radiation safety practices should be
part of professional certiﬁcation processes and incorporated
into maintenance of certiﬁcation programs. Compared with
current standards, an increased rigor for radiation safety
curricula is likely required for laboratory accreditation, board
certiﬁcation, and maintenance of certiﬁcation requirements.
Although an adequate knowledge of radiation risk is essen-
tial for imagers, a modicum of understanding is also nec-
essary for referring physicians. Education aimed at ensuring
a sufﬁcient knowledge base for all physicians should begin
in medical school, where educational programs have been
demonstrated to improve knowledge of radiological pro-
tection practices (44).
Fundamental tools for laboratory reporting and tracking:
performance measures and DRLs. Recent work by the
American College of Cardiology Foundation and the
American Heart Association Task Force on Performance
Measures identiﬁed 2 speciﬁc types of performance measures
that may be particularly helpful in evaluating the use of
cardiovascular technology: appropriate use measures and
structure, safety measures (46). For studies that expose pa-
tients to ionizing radiation, at least 1 pertinent appropriate
use measure and 1 dosimetric safety measure should be
identiﬁed and recorded for each procedure. It is recom-
mended that these measures be incorporated as part of the
patient’s ﬁnal report, as a necessary requirement of stan-
dardized reporting (46). Initial efforts in terms of appropriate
use measures should focus on the overall rate of inappropriate
Table 3 Possible Text for Physician–Patient Interaction About Radiation Dose From Cardiac Imaging Procedures*y
Effective Dose Level
for Protocol (mSv) Suggested Language
3 The test you are about to have provides useful information about your health. This test uses radiation to provide this information.
We are all exposed to radiation from natural sources every day. The small amount of radiation to a typical patient from today’s test is less
than what most Americans are exposed to from their surroundings during 1 year of their life. The risk of this procedure is very low.
>3–20 The test you are about to have provides useful information about your health. This test uses radiation to provide this information.
We are all exposed to radiation from natural sources every day. The amount of radiation to a typical patient from today’s test is similar
to or greater than what most Americans are exposed to every year from their surroundings. However, it is similar to or less than the
maximum that is recommended in a typical year for people exposed to radiation as part of their job.
Although experts are not certain, some evidence suggests that there may be a very small increase in your risk of developing cancer at a later
age, related to the radiation from this test. This risk is considered to be similar to the risks of many everyday activities and medical
procedures.
Your healthcare provider believes that the beneﬁts of this test outweigh this small potential risk.
You may have had tests that used radiation in the past. To the best of our current knowledge, your risk from today’s test is not affected by
how much radiation you have received from previous tests.
>20–50 The test that you are about to have provides useful information about your health. This test uses radiation to provide this information.
We are all exposed to radiation from natural sources every day. The amount of radiation to a typical patient from today’s test is greater than
what most Americans are exposed to every year from their surroundings. It is also greater than what is recommended for people exposed
to radiation in a typical year as part of their job. Although experts are not certain, some evidence suggests that there may be a small
increase in your risk of developing cancer at a later age, related to the radiation from this test.
Your healthcare provider believes that the beneﬁts of this test outweigh this small potential risk of developing cancer.
You may have had tests that used radiation in the past. To the best of our current knowledge, your risk from today’s test is not affected by
how much radiation you have received from previous tests.
*Note that dose levels are those for a typical patient undergoing the protocol; the concept of effective dose is not designed for patient-level dosimetry, and doses to individual patients may vary on the basis of
patient-speciﬁc characteristics such as weight, habitus, heart rate, and so on. yText is provided only for protocols with effective doses up to 50 mSv. No cardiac imaging procedure in a general population
should have a typical effective dose of more than 50 mSv. If a physician anticipates such a level of radiation, the physician–patient interaction needs to be carefully tailored to the patient, test, and clinical
scenario.
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1485(now termed “rarely appropriate”) (14) use as well as rates of
use for the most commonly used inappropriate indications,
such as those identiﬁed in the American Board of Internal
Medicine’s Choosing Wisely (15) recommendations.
As requirements for laboratory accreditation, continuous
quality initiatives should be aimed toward the optimization
of radiation dose reduction practices, with a simultaneous
goal of optimal diagnostic performance. Presently, imaging
societies set standards for laboratory safety, imaging pro-
tocols, interpretation, and standardized reporting, as pub-
lished in consensus statements and guidelines (8–11).
Guidelines with regard to radiation exposure are increas-
ingly providing content that offers guidance on the basis
of a speciﬁc, data-driven level of radiation delivered for
a speciﬁc routine examination protocol. Such a radiation
dose level is termed a DRL (47). DRLs are often deﬁned
in terms of a particular percentile (e.g., the 75th percentile)
of the distribution of dose metrics for a particular study in
a particular population. One beneﬁt of deﬁning a DRL is
that it makes possible the identiﬁcation of situations in
which patient dose is unusually high. The use of DRLs, as
a standardized tool for continuous quality initiatives, could
be used to elicit improvements in mean radiation dose for
a given laboratory.
Although already developed in other patient populations
(e.g., pediatric CT imaging) (48,49), DRLs have not yet
been established for standard cardiac imaging procedures. A
new recommendation arising from this symposium is that
DRLs should be developed for a variety of speciﬁc cardiac
imaging indications (e.g., SPECT myocardial perfusion
imaging in patients with chest pain, asymptomatic screeningwith coronary artery calcium scoring). This will require
considerable effort and should be an important new initia-
tive for the ﬁeld.
We identiﬁed the >20-mSv threshold for a single pro-
cedure, although not formally a DRL, as an important
metric to identify patients requiring more intensive dis-
cussions on radiation-related risk. It was the consensus of
symposium participants that monitoring utilization prac-
tices that exceed this threshold was an important goal that
should be monitored through laboratory accreditation
quality initiatives. Currently, CT accreditation requires
laboratories to develop procedures for tracking of patient
radiation doses; this information is reviewed during audit or
site visits. On the basis of the present symposium, minimal
and justiﬁed use of procedures using protocols with effective
doses >20 mSv should be tracked, with excess exposure
beyond this level limited to a speciﬁed proportion of pa-
tients. In the case of >20 mSv, higher exposures may be
acceptable for the very elderly, in whom radiation risk is very
small and the prevalence of coronary artery disease is high
(i.e., the beneﬁt/risk ratio balance is high). Of note,
simplistic methods of estimating effective dose (a size-
independent metric) such as multiplying dose-length
product by a conversion factor, may result in erroneously
high estimates when applied to obese patients. In obese
patients in whom suboptimal image quality is of concern, a
protocol with an effective dose of >20 mSv when estimated
in such a manner may not be associated with higher actual
absorbed doses to critical organs in the particular patient.
Such estimates should not be used to deny services to
patients who could beneﬁt. Likewise, laboratories that
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patients should not be penalized in activities that attempt to
benchmark laboratory quality.
A second charge for societal guidelines is to set re-
quirements for the collection and reporting of radiation dose
practices from a laboratory database. Databases should have
the capabilities of reporting radiation dose for a consecutive
series of a laboratory’s patient population. Societal guidelines
should also detail the processes for documentation and the
quality improvement initiatives, which should be linked to
DRLs. Standards for image quality and diagnostic perfor-
mance should be coupled with reporting rates of procedures
that are in accordance with DRL-based radiation safety
standards, in the form of a laboratory quality score.
Laboratories should maintain a database for tracking of
radiation dosimetric safety metrics for all patients undergo-
ing ionizing radiation procedures as a cumulative quality
performance measure. Harmonization of the common data
elements used for radiation dose measurement and reporting
should be developed by imaging societies in collaboration
with all diagnostic radiation stakeholders, including patient
representatives. Value-based reimbursement incentives
should be considered, which may improve the success of this
important effort.
Public reporting. Although not currently available or
required, the development of databases of radiation dosi-
metric safety metrics and the establishment of DRLs, more
reﬁned, data-driven report cards should be developed.
Radiation dose databases, including consecutive series of
cases, should be required for accreditation, certiﬁcation, and
maintenance of certiﬁcation purposes to enable laboratory
tracking and reporting of patient radiation doses. Accredit-
ing bodies, such as the Intersocietal Accreditation Com-
mission, the American College of Radiology, and the Joint
Commission, should collect unselected data from labora-
tories and publicly report performance measures such as
distributions of dosimetric safety measures, which can be
used to track the frequency with which studies exceed the
designated DRL. As well, these reports should be used by
laboratories to measure their radiation reduction perfor-
mance efforts.
Issues of test layering, dose tracking, and substitution.
One issue that is ill deﬁned is the appropriate indications
for serial testing within an episode of care. Although radiation
dose levels may be optimized for each individual test
contributing to a diagnostic workup, the layering of multiple
tests increases the cumulative radiation exposure. Although a
past history may include frequent testing, ultimately each
individual test involving ionizing radiation needs to be justi-
ﬁed independently, since the beneﬁt/risk ratio of a given
procedure is independent of whether the patient has received
many previous tests or none. Speciﬁcally, under the linear
no-threshold model (presently regarded as the best simple
model describing the relationship between radiation dose and
risk), the projected risk for a given procedure is considered to
be independent of prior testing (50,51). Nevertheless, theInternational Basic Safety Standards suggest that relevant
information from a patient’s previous radiological procedures
should be taken into account in justifying a speciﬁc procedure
involving radiation (52).
Indeed, numerous organizations, such as the Interna-
tional Atomic Energy Agency, the World Health Organi-
zation, and the U.S. Food and Drug Administration, now
advocate longitudinal patient radiation dose tracking (53).
Although not yet implemented in any country on a national
level, it is beginning to be implemented across some
healthcare systems (54), and there is widespread global in-
terest in such cumulative dose tracking (55). Goals of
tracking include supporting accountability for patient safety,
strengthening justiﬁcation by enabling patient-speciﬁc data-
informed decision making for referring providers, support-
ing optimization including enabling DRL development,
providing information for risk assessment, and facilitating
research and epidemiologic investigations (53). One
particularly important clinical aim of collecting longitudinal
patient dose information is to minimize unnecessary,
duplicate imaging use during and across episodes of care.
Without this information, repeat imaging may occur
without physician knowledge of prior procedures performed
in laboratories at different facilities. However, some experts
argue that tracking of numbers and types of procedures
alone will accomplish this latter aim and that tracking of
cumulative doses across systems would be an extensive un-
dertaking with the potential downside of misunderstanding
of radiation dose history and consequent alarmism and
avoidance of clinically indicated procedures involving
ionizing radiation. A full treatment of the beneﬁts and
pitfalls of radiation dose tracking is beyond the scope of this
document.
Importantly, the guideline-accepted diagnostic workup of
patients often includes the performance of conﬁrmatory,
diagnostic procedures after index testing demonstrating
abnormal or indeterminate ﬁndings. Better characterization
is needed of cumulative radiation dose levels that are neces-
sary to complete an evaluation for a given diagnostic strat-
egy or episode of care (e.g., the outpatient workup of chest
pain).
In today’s practice, test substitution of a nonionizing ra-
diation test for a CT or nuclear cardiologic procedure is
common. Test substitution can be a beneﬁcial practice, if it
is evidence based, such as the shifting of low-risk women
from stress nuclear procedures to routine exercise treadmill
tests (19,20,56). Even so, caution must be exercised, and
routinized test substitution practices should be avoided. The
International Commission on Radiological Protection, in
deﬁning the safety principle of justiﬁcation, clariﬁed that “by
introducing a new radiation source, by reducing existing
exposure, or by reducing the risk of potential exposure, one
should achieve sufﬁcient individual or societal beneﬁt to
offset the detriment it causes” (40). Thus, test substitution
requires a patient-centered beneﬁt/risk rationale and should
not be performed solely because of radiation exposure.
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1487Conclusions. Safety, image quality, and diagnostic perfor-
mance are key elements of a laboratory’s quality. Primary
efforts should be directed toward avoiding testing in patients
who do not need it and, importantly, supporting testing
where appropriate. Improved laboratory adherence to ap-
propriate use criteria (19,20) and clinical practice guideline
recommendations (56) are an important means to guide
effective testing utilization patterns. Standardized reporting
and development of DRLs for CT imaging and nuclear
cardiology are important for the primary goal of public
reporting of laboratory radiation dose levels in conjunction
with image quality and diagnostic performance.
Focus on Population Reporting and Tracking
To effectively reduce the radiation exposure associated with
diagnostic imaging, it is important to consider multiple
approaches when evaluating population-based methods. The
most likely method to reduce population radiation exposure
is to minimize test use for referral indications classiﬁed as
inappropriate or rarely appropriate (10). Thus, the popula-
tion track strongly endorsed the use of decision support
tools at the point of physician order entry to promote
appropriate referral patterns that would improve justiﬁcation
for radiation exposure and thereby foster population-wide
reductions in radiation exposure. Prior research supports
that a single-pronged approach is ineffective at improving
physician education and behavioral change (57,58). As such,
continuous quality initiative efforts should be implemented
and include physician feedback at all levels within the or-
dering and care management pathways as well as including
“real-time” educational interventions.
Substantially different radiation doses have been demon-
strated from similar tests performed at different institutions,
and population-based approaches offer the opportunity to
decrease unnecessary variability across patient cohorts. There
are a number of nascent examples of such efforts, including
the Advanced Cardiovascular Imaging Consortium and
the upcoming ASNC registries (1,3,4).
The Advanced Cardiovascular Imaging Consortium is
an ongoing quality improvement program incorporating 40
imaging centers in the state of Michigan that provide cor-
onary CT angiographic services (2–4,59). The program is
funded by BlueCross BlueShield of Michigan, and par-
ticipation is required for reimbursement. Data collected
include demographics, procedural indications, technical de-
tails including radiation doses, and clinical outcomes
through 90 days of follow-up. An essential part of the
continuous quality initiative process is a quarterly report for
participating sites that enables cross-center comparisons on
an array of quality metrics. A dose reduction “best practice”
algorithm was established early as part of a consortium-
wide intervention, and this algorithm is regularly revised
to incorporate improving technology. Sites are required
to present their quality improvement methods annually,
resulting in steady declines in median radiation dose (2).ASNC is currently embarking on pilot projects that will
provide the means to develop a multisite laboratory registry.
The ASNC registry is entitled ImageGuide and, in 2014,
will initiate enrollment of consecutive series of patients
across diverse laboratories, from the private practice setting
to academic medical centers. The primary aims of the
ASNC registry will be to document timely reporting, mea-
sure adherence to standardized reporting measures, develop
standardized rates of appropriate and rarely appropriate
studies (notably by key patient [e.g., sex, race, income]
and physician [e.g., laboratory volume] characteristics), and
develop an effective strategy for public reporting of perfor-
mance measures including radiation exposure. An important
long-term goal of this registry will be public reporting of
laboratory practice patterns of radiation safety, including
median dose, dose reduction practices, and rates of rarely
appropriate studies.
As registries expand, it will be important for radiation
tracking to develop standardized assessments of cumulative
dose per episode of care. This will entail connectivity with
current population-wide registries (such as the American
College of Cardiology’s National Cardiovascular Data
Registry). Subsets of patients who may receive larger
amounts of radiation (e.g., those undergoing multiple nu-
clear stress tests [57]) or those with a greater projected ra-
diation risk (e.g., younger patients) should, in particular, be
targeted for tracking purposes. These registries could also
be used to target complex patient and provider proﬁles for
those who more often receive unnecessary additional testing.
We suggest applying the term “vulnerable populations” to
patient subsets, such as children or younger patients, whose
life expectancy may increase projected cancer risk estimates
after radiation exposure. A summary of recommendations
for laboratory and population tracking of radiation is pro-
vided in Table 4.
Symposium Conclusions
A synopsis of recommendations reveals 3 areas where radi-
ation safety efforts are to be prioritized by professional or-
ganizations, including a focus on patient, laboratory, and
population safety. The concepts discussed in this document
can form the basis for strategic priorities to target educa-
tional programs for shared decision making and healthcare
provider knowledge in radiation safety practices. As well,
laboratory reporting of radiation dosimetry is a critical
component of creating the patient-centered laboratory
that fosters a caring environment with procedural methods
transparent to patients. A protocol effective dose of>20 mSv
is proposed in this document as a level requiring particular
attention in terms of shared decision making and either a
formal discussion or written informed consent. Cumulative
dose measures for a given episode of care and subset ana-
lyses of vulnerable patient populations should be planned
elements in the radiation-tracking programs. Large regis-
tries to encourage widespread, public reporting of laboratory
Table 4
Summary of Level of Recommendations for Laboratory-
Based and Population-Based Radiation Reduction
Recommendation 2013 Level
Reporting of appropriate use criteria categories of




Development of DRLs for a variety of speciﬁc cardiac
imaging tasks
Required*
Implementation of continuous quality improvement
programs
Required*
Implementation of decision support tools Recommendedy
Continuing medical education for referring physicians Recommendedy
Creation of a repository from electronic health record
data on each patient’s history of medical imaging
radiation exposure
Suggestedz
Although these recommendations were made in 2013, it should be emphasized that all recom-
mendations should in time become mandatory. *Majority opinion that standardized laboratory
practice of this recommendation is consistent with effective, patient-centered imaging. yGeneral
agreement that standardized laboratory practice of this recommendation would enhance patient-
centered imaging. zExpert opinion that standardized laboratory practice of this recommendation
would enhance patient-centered imaging.
DRL ¼ diagnostic reference level.
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1488radiation dosimetry are being developed, and DRLs for
cardiac imaging should be developed. Additional com-
parative effectiveness research is needed to justify radiation
exposure compared with tests that do not expose patients to
ionizing radiation or to lower exposure testing options.
The creation of patient-centered imaging laboratories that
prioritize patient safety and effectiveness will require sizable
changes to the culture of imaging, which now focuses on
volume and efﬁciency. With regard to radiation safety, core
principles to guide measurement and quality efforts are
detailed in Table 5. Patient groups, payers, and the clinical
community have expressed the need to place a greater
emphasis on justiﬁcation of use and widespread adoption
of radiation dose optimization strategies.
The development of current cardiac imaging technologies
revolutionized the practice of cardiovascular medicine by
allowing the routine, noninvasive assessment of myocardial
perfusion and anatomy. It is now incumbent on the imaging
community to create an accountability framework to safely
drive appropriate imaging utilization.
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Three Basic Principles to Guide Patient-Centered
Imaging and Exposure to Ionizing Radiation
1. Justiﬁcation principle: beneﬁts and risks of all testing options should be
compared, and if an exposure cannot be justiﬁed, the test should not be
performed
2. Optimization principle: all doses due to medical exposure must be kept as low as
reasonably achievable
3. Responsibility principle: both the referrer and the imager are responsible for
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